Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population
Recruiting
Observational Study
Intracardiac Thrombus
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 1 Month – 16
- Sex
- Any
- Study type
- Observational
- Participants needed
- 20 (estimated)
- Sponsor
- Azienda Ospedaliero, Universitaria Ospedali Riuniti · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to determine the efficacy of rivaroxaban treatment for intracardiac thrombi resolution in pediatric patients (\< 16 years old) diagnosed with intracardiac thrombosis. The main question it aims to answer is: Does rivaroxaban treatment resolve the thrombosis during a 3-month treatment?
Participants already taking rivaroxaban as part of their regular medical c…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Intracardiac thrombosis demonstration at echocardiography and CMR/CCT confirmation
* Given informed consent from the parents or tutors
Exclusion Criteria:
* \< 38 weeks of gestational birth
* \< 10 days of oral feeding and body weight
* \< 2.6 Kg
* Any major or clinically re…
Contacts